1[1]Botto H, Lebret T, Barre P, et al. Electrovaporization of prostate with the Gyrus Device. J Endourology, 2001, 15∶319-322. 被引量：1
2[2]Melekos M D, Moutzouris G D. Intravesical therapy of superficial bladder cancer. Curr-Pharm-Des, 2000, 6∶345-359. 被引量：1
3[3]Metts M C, Metts J C, Milito S J, et al. Bladder cancer: a review of diagnosis and management. J Natl Med Assoc, 2000, 92∶285-294. 被引量：1
4[4]Hahn RG. Transurethral resection syndrome after transurethral resection of bladder tumours. Can J Anaesth, 1995, 42∶69-72. 被引量：1
5[5]Virdi J, Kapasi F, Chandrasekar P, et al. A prospective randomized study between transurethral vaporization using Plasma Kinetic Energy and transurethral resection of the prostate. J Urol, 2000, 163(4, suppl 1192)∶268-269. 被引量：1
6[6]Donovan J L, Peters T J, Neal D E, et al. A randomized trial comparing transurethral resection of the prostate, laser therapy and conservative treatment of men with symptoms associated with benign prostatic enlargement: The clasp study.J Urol, 2000, 164∶65-70. 被引量：1
7[7]Ozen H, Hall M C. Bladder cancer. Curr Opin Oncol, 2000, 12∶255-259. 被引量：1
8[8]Zietman A L, Shipley W U, Kaufman D S. Organ-conserving approaches to muscle-invasive bladder cancer: future alternatives to radical cystectomy. Ann-Med, 2000, 32∶34-42. 被引量：1
9[1]Ramsey EW. Benign prostatic hyperplasia: a review. Can J Urol,2000,7:1 135 被引量：1
10[2]Mebust W, Holtgrewe H, Cocket APC, et al. Transurethral prostectomy: immediate and post operative complication. Acomparative study of 13 participating institution evaluating 3885 patients. J Urol,1989,141:243 被引量：1
